135 related articles for article (PubMed ID: 34006333)
1. Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients.
Valle-Inclan JE; Stangl C; de Jong AC; van Dessel LF; van Roosmalen MJ; Helmijr JCA; Renkens I; Janssen R; de Blank S; de Witte CJ; Martens JWM; Jansen MPHM; Lolkema MP; Kloosterman WP
Genome Med; 2021 May; 13(1):86. PubMed ID: 34006333
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
Valpione S; Campana L
Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
[TBL] [Abstract][Full Text] [Related]
3. PACT: a pipeline for analysis of circulating tumor DNA.
Webster J; Dang HX; Chauhan PS; Feng W; Shiang A; Harris PK; Pachynski RK; Chaudhuri AA; Maher CA
Bioinformatics; 2023 Aug; 39(8):. PubMed ID: 37549060
[TBL] [Abstract][Full Text] [Related]
4. NanoVar: accurate characterization of patients' genomic structural variants using low-depth nanopore sequencing.
Tham CY; Tirado-Magallanes R; Goh Y; Fullwood MJ; Koh BTH; Wang W; Ng CH; Chng WJ; Thiery A; Tenen DG; Benoukraf T
Genome Biol; 2020 Mar; 21(1):56. PubMed ID: 32127024
[TBL] [Abstract][Full Text] [Related]
5. Benchmarking long-read aligners and SV callers for structural variation detection in Oxford nanopore sequencing data.
Helal AA; Saad BT; Saad MT; Mosaad GS; Aboshanab KM
Sci Rep; 2024 Mar; 14(1):6160. PubMed ID: 38486064
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy: unlocking the potentials of cell-free DNA.
Chu D; Park BH
Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Germline Structural Variant Calling Methods for Nanopore Sequencing Data.
Bolognini D; Magi A
Front Genet; 2021; 12():761791. PubMed ID: 34868242
[TBL] [Abstract][Full Text] [Related]
8. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
[TBL] [Abstract][Full Text] [Related]
9. Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors.
Zollinger DR; Rivers E; Fine A; Huang Y; Son J; Kalyan A; Gray W; Baharian G; Hammond C; Ram R; Ringman L; Hafez D; Savel D; Patel V; Dantone M; Guo C; Childress M; Xu C; Johng D; Wallden B; Pokharel P; Camara W; Hegde PS; Hughes J; Carter C; Davarpanah N; Degaonkar V; Gupta P; Mariathasan S; Powles T; Ferree S; Dennis L; Young A
PLoS One; 2024; 19(5):e0302129. PubMed ID: 38753705
[TBL] [Abstract][Full Text] [Related]
10. Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations.
Galbiati S; Damin F; Ferraro L; Soriani N; Burgio V; Ronzoni M; Gianni L; Ferrari M; Chiari M
Cells; 2019 Jul; 8(8):. PubMed ID: 31344983
[No Abstract] [Full Text] [Related]
11. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
[TBL] [Abstract][Full Text] [Related]
12. A recurrence-based approach for validating structural variation using long-read sequencing technology.
Zhao X; Weber AM; Mills RE
Gigascience; 2017 Aug; 6(8):1-9. PubMed ID: 28873962
[TBL] [Abstract][Full Text] [Related]
13. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
[TBL] [Abstract][Full Text] [Related]
14. Aperture: alignment-free detection of structural variations and viral integrations in circulating tumor DNA.
Liu H; Yin H; Li G; Li J; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368852
[TBL] [Abstract][Full Text] [Related]
15. SVLR: Genome Structural Variant Detection Using Long-Read Sequencing Data.
Gu W; Zhou A; Wang L; Sun S; Cui X; Zhu D
J Comput Biol; 2021 Aug; 28(8):774-788. PubMed ID: 33973820
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection.
Fiala C; Diamandis EP
Clin Chem Lab Med; 2020 Sep; 58(10):1651-1653. PubMed ID: 32160156
[TBL] [Abstract][Full Text] [Related]
17. Identification of Structural Variation in Chimpanzees Using Optical Mapping and Nanopore Sequencing.
Soto DC; Shew C; Mastoras M; Schmidt JM; Sahasrabudhe R; Kaya G; Andrés AM; Dennis MY
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32143403
[TBL] [Abstract][Full Text] [Related]
18. Enrichment and Analysis of ctDNA.
Gilson P
Recent Results Cancer Res; 2020; 215():181-211. PubMed ID: 31605230
[TBL] [Abstract][Full Text] [Related]
19. Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer.
Keup C; Suryaprakash V; Hauch S; Storbeck M; Hahn P; Sprenger-Haussels M; Kolberg HC; Tewes M; Hoffmann O; Kimmig R; Kasimir-Bauer S
Genome Med; 2021 May; 13(1):85. PubMed ID: 34001236
[TBL] [Abstract][Full Text] [Related]
20. Picky comprehensively detects high-resolution structural variants in nanopore long reads.
Gong L; Wong CH; Cheng WC; Tjong H; Menghi F; Ngan CY; Liu ET; Wei CL
Nat Methods; 2018 Jun; 15(6):455-460. PubMed ID: 29713081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
